{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:50:55Z","timestamp":1783075855215,"version":"3.54.6"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["KAKENHI Grant (18K09464)"],"award-info":[{"award-number":["KAKENHI Grant (18K09464)"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Fuchs endothelial corneal dystrophy (FECD) remains a leading cause of corneal blindness globally, with corneal transplantation being the primary treatment. FECD is characterized by the formation of guttae, extracellular matrix (ECM) deposits beneath the corneal endothelium, and progressive endothelial cell loss. These pathological changes cause visual deterioration through light scattering by guttae and corneal edema due to endothelial cell loss. However, limitations such as donor shortage and graft failure necessitate alternative therapeutic approaches. We employed computational drug screening using three platforms (L1000FWD, L1000CDS<jats:sup>2<\/jats:sup>, and SigCom LINCS) to identify compounds capable of normalizing FECD-associated differentially expressed genes (DEGs). Analysis of transcriptome data from FECD patients with <jats:italic>TCF4<\/jats:italic>trinucleotide repeat expansion identified 706 upregulated and 962 downregulated genes. The screening platforms identified 200, 35, and 76 compounds through L1000FWD, L1000CDS<jats:sup>2<\/jats:sup>, and SigCom LINCS, respectively, with five compounds commonly predicted across all platforms. Among these, LDN193189 and cercosporin were selected for further evaluation based on availability and lack of cytotoxicity. Both compounds significantly decreased the expression of ECM-related genes (<jats:italic>FN1<\/jats:italic>, <jats:italic>MATN3<\/jats:italic>, <jats:italic>BGN<\/jats:italic>, and <jats:italic>LTBP2<\/jats:italic>) in FECD cell models and suppressed TGF-\u03b2-induced fibronectin expression. Additionally, both compounds reduced aggresome formation to normal control levels, suggesting protection against endoplasmic reticulum stress-induced cell death. This study demonstrates the feasibility of computational drug screening for identifying therapeutic candidates for FECD, with LDN193189 and cercosporin showing promise in normalizing FECD-associated pathological changes.<\/jats:p>","DOI":"10.1038\/s41598-025-95003-z","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T11:11:48Z","timestamp":1745665908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A feasibility of computational drug screening for Fuchs endothelial corneal dystrophy"],"prefix":"10.1038","volume":"15","author":[{"given":"Itsuki","family":"Oka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Toyokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouta","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theofilos","family":"Tourtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Schl\u00f6tzer-Schrehardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"95003_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/bs.pmbts.2015.04.005","volume":"134","author":"AO Eghrari","year":"2015","unstructured":"Eghrari, A. O., Riazuddin, S. A. & Gottsch, J. D. Fuchs corneal dystrophy. Prog Mol. Biol. Transl Sci. 134, 79\u201397. https:\/\/doi.org\/10.1016\/bs.pmbts.2015.04.005 (2015).","journal-title":"Prog Mol. Biol. Transl Sci."},{"key":"95003_CR2","doi-asserted-by":"publisher","first-page":"100883","DOI":"10.1016\/j.preteyeres.2020.100883","volume":"81","author":"MP Fautsch","year":"2021","unstructured":"Fautsch, M. P. et al. TCF4-mediated Fuchs endothelial corneal dystrophy: insights into a common trinucleotide repeat-associated disease. Prog Retin Eye Res. 81, 100883. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100883 (2021).","journal-title":"Prog Retin Eye Res."},{"key":"95003_CR3","doi-asserted-by":"publisher","first-page":"100863","DOI":"10.1016\/j.preteyeres.2020.100863","volume":"80","author":"S Ong Tone","year":"2021","unstructured":"Ong Tone, S. et al. Fuchs endothelial corneal dystrophy: the vicious cycle of Fuchs pathogenesis. Prog Retin Eye Res. 80, 100863. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100863 (2021).","journal-title":"Prog Retin Eye Res."},{"key":"95003_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2174\/1874364101812010154","volume":"12","author":"N Okumura","year":"2018","unstructured":"Okumura, N., Hayashi, R. & Koizumi, N. Perspective of future potent therapies for Fuchs endothelial corneal dystrophy. Open. Ophthalmol. J. 12, 154\u2013163. https:\/\/doi.org\/10.2174\/1874364101812010154 (2018).","journal-title":"Open. Ophthalmol. J."},{"key":"95003_CR5","doi-asserted-by":"publisher","first-page":"104047","DOI":"10.1016\/j.dib.2019.104047","volume":"25","author":"AS Nikitina","year":"2019","unstructured":"Nikitina, A. S. et al. Dataset on transcriptome profiling of corneal endothelium from patients with Fuchs endothelial corneal dystrophy. Data Brief. 25, 104047. https:\/\/doi.org\/10.1016\/j.dib.2019.104047 (2019).","journal-title":"Data Brief."},{"key":"95003_CR6","doi-asserted-by":"publisher","first-page":"e000321","DOI":"10.1136\/bmjophth-2019-000321","volume":"4","author":"SV Patel","year":"2019","unstructured":"Patel, S. V. Towards clinical trials in Fuchs endothelial corneal dystrophy: classification and outcome Measures-The Bowman club lecture 2019. BMJ Open. Ophthalmol. 4, e000321. https:\/\/doi.org\/10.1136\/bmjophth-2019-000321 (2019).","journal-title":"BMJ Open. Ophthalmol."},{"key":"95003_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/08820538.2022.2152717","volume":"38","author":"S Singh","year":"2023","unstructured":"Singh, S. & Chaurasia, S. Recent and evolving therapies in the management of endothelial diseases. Semin Ophthalmol. 38, 207\u2013215. https:\/\/doi.org\/10.1080\/08820538.2022.2152717 (2023).","journal-title":"Semin Ophthalmol."},{"key":"95003_CR8","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1093\/nar\/gkaa422","volume":"48","author":"Y Chu","year":"2020","unstructured":"Chu, Y. et al. Analyzing pre-symptomatic tissue to gain insights into the molecular and mechanistic origins of late-onset degenerative trinucleotide repeat disease. Nucleic Acids Res. 48, 6740\u20136758. https:\/\/doi.org\/10.1093\/nar\/gkaa422 (2020).","journal-title":"Nucleic Acids Res."},{"key":"95003_CR9","doi-asserted-by":"publisher","first-page":"8647","DOI":"10.1038\/s41598-023-35468-y","volume":"13","author":"T Nakagawa","year":"2023","unstructured":"Nakagawa, T. et al. RNA-Seq\u2013based transcriptome analysis of corneal endothelial cells derived from patients with Fuchs endothelial corneal dystrophy. Sci. Rep. 13, 8647 (2023).","journal-title":"Sci. Rep."},{"key":"95003_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1167\/iovs.65.6.27","volume":"65","author":"T Honda","year":"2024","unstructured":"Honda, T. et al. Dysregulation of the TCF4 isoform in corneal endothelial cells of patients with Fuchs endothelial corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 65, 27. https:\/\/doi.org\/10.1167\/iovs.65.6.27 (2024).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95003_CR11","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1093\/bioinformatics\/bty060","volume":"34","author":"Z Wang","year":"2018","unstructured":"Wang, Z., Lachmann, A., Keenan, A. B. & Ma\u2019Ayan, A. L1000FWD: fireworks visualization of drug-induced transcriptomic signatures. Bioinformatics 34, 2150\u20132152 (2018).","journal-title":"Bioinformatics"},{"issue":"2","key":"95003_CR12","doi-asserted-by":"publisher","first-page":"16015","DOI":"10.1038\/npjsba.2016.15","volume":"L1000CDS","author":"Q Duan","year":"2016","unstructured":"Duan, Q. et al. LINCS L1000 characteristic direction signatures search engine. NPJ Syst. Biol. Appl. 2. L1000CDS (2), 16015. https:\/\/doi.org\/10.1038\/npjsba.2016.15 (2016).","journal-title":"NPJ Syst. Biol. Appl. 2"},{"key":"95003_CR13","doi-asserted-by":"publisher","first-page":"W697","DOI":"10.1093\/nar\/gkac328","volume":"50","author":"JE Evangelista","year":"2022","unstructured":"Evangelista, J. E. et al. SigCom LINCS: data and metadata search engine for a million gene expression signatures. Nucleic Acids Res. 50, W697\u2013W709. https:\/\/doi.org\/10.1093\/nar\/gkac328 (2022).","journal-title":"Nucleic Acids Res."},{"key":"95003_CR14","doi-asserted-by":"publisher","first-page":"D558","DOI":"10.1093\/nar\/gkx1063","volume":"46","author":"A Koleti","year":"2018","unstructured":"Koleti, A. et al. Data portal for the library of integrated Network-based cellular signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data. Nucleic Acids Res. 46, D558\u2013D566. https:\/\/doi.org\/10.1093\/nar\/gkx1063 (2018).","journal-title":"Nucleic Acids Res."},{"key":"95003_CR15","doi-asserted-by":"publisher","first-page":"116528","DOI":"10.1016\/j.biopha.2024.116528","volume":"174","author":"Y Yu","year":"2024","unstructured":"Yu, Y. et al. Predicting potential therapeutic targets and small molecule drugs for early-stage lung adenocarcinoma. Biomed. Pharmacother. 174, 116528. https:\/\/doi.org\/10.1016\/j.biopha.2024.116528 (2024).","journal-title":"Biomed. Pharmacother"},{"key":"95003_CR16","doi-asserted-by":"publisher","first-page":"21195","DOI":"10.1038\/s41598-024-70659-1","volume":"14","author":"Z Wen","year":"2024","unstructured":"Wen, Z. & Ablimit, A. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals ubiquitin promotes pulmonary fibrosis in chronic pulmonary diseases. Sci. Rep. 14, 21195. https:\/\/doi.org\/10.1038\/s41598-024-70659-1 (2024).","journal-title":"Sci. Rep."},{"key":"95003_CR17","doi-asserted-by":"publisher","first-page":"109043","DOI":"10.1016\/j.abb.2021.109043","volume":"712","author":"F Khanjani","year":"2021","unstructured":"Khanjani, F. et al. Drug repositioning based on gene expression data for human HER2-positive breast cancer. Arch. Biochem. Biophys. 712, 109043. https:\/\/doi.org\/10.1016\/j.abb.2021.109043 (2021).","journal-title":"Arch. Biochem. Biophys."},{"key":"95003_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2019.08.002","volume":"465","author":"EA Choi","year":"2019","unstructured":"Choi, E. A. et al. A Pharmacogenomic analysis using L1000CDS(2) identifies BX-795 as a potential anticancer drug for primary pancreatic ductal adenocarcinoma cells. Cancer Lett. 465, 82\u201393. https:\/\/doi.org\/10.1016\/j.canlet.2019.08.002 (2019).","journal-title":"Cancer Lett."},{"key":"95003_CR19","doi-asserted-by":"publisher","unstructured":"Qian, Y., Itzel, T., Ebert, M. & Teufel, A. Deep view of HCC gene expression signatures and their comparison with other cancers. Cancers (Basel). 14. https:\/\/doi.org\/10.3390\/cancers14174322 (2022).","DOI":"10.3390\/cancers14174322"},{"key":"95003_CR20","doi-asserted-by":"publisher","first-page":"720170","DOI":"10.3389\/fphar.2021.720170","volume":"12","author":"PN Pushparaj","year":"2021","unstructured":"Pushparaj, P. N., Kalamegam, G., Wali Sait, K. H. & Rasool, M. Decoding the role of astrocytes in the entorhinal cortex in Alzheimer\u2019s disease using High-Dimensional Single-Nucleus RNA sequencing data and Next-Generation knowledge discovery methodologies: focus on drugs and natural product remedies for dementia. Front. Pharmacol. 12, 720170. https:\/\/doi.org\/10.3389\/fphar.2021.720170 (2021).","journal-title":"Front. Pharmacol."},{"key":"95003_CR21","doi-asserted-by":"publisher","unstructured":"Cavalli, E. et al. Exploratory analysis of iPSCS-Derived neuronal cells as predictors of diagnosis and treatment of alzheimer disease. Brain Sci. 10 https:\/\/doi.org\/10.3390\/brainsci10030166 (2020).","DOI":"10.3390\/brainsci10030166"},{"key":"95003_CR22","doi-asserted-by":"publisher","unstructured":"Papadopoulou, D. et al. Repurposing the antipsychotic drug Amisulpride for targeting synovial fibroblast activation in arthritis. JCI Insight. 8 https:\/\/doi.org\/10.1172\/jci.insight.165024 (2023).","DOI":"10.1172\/jci.insight.165024"},{"key":"95003_CR23","doi-asserted-by":"publisher","unstructured":"Chen, S. et al. Bioinformatic analysis of key regulatory genes in adult asthma and prediction of potential drug candidates. Molecules 28 https:\/\/doi.org\/10.3390\/molecules28104100 (2023).","DOI":"10.3390\/molecules28104100"},{"key":"95003_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.688227","author":"PN Pushparaj","year":"2021","unstructured":"Pushparaj, P. N., Abdulkareem, A. A. & Naseer, M. I. Focus on Neuro-COVID and Potential Therapeutics. Front. Pharmacol. 12, 688227. https:\/\/doi.org\/10.3389\/fphar.2021.688227 (2021). Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models:."},{"key":"95003_CR25","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1007\/s00018-018-2911-z","volume":"75","author":"N Vuokila","year":"2018","unstructured":"Vuokila, N. et al. miR-124-3p is a chronic regulator of gene expression after brain injury. Cell. Mol. Life Sci. 75, 4557\u20134581. https:\/\/doi.org\/10.1007\/s00018-018-2911-z (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"95003_CR26","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1016\/j.bmcl.2008.06.052","volume":"18","author":"GD Cuny","year":"2008","unstructured":"Cuny, G. D. et al. Structure\u2013activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg. Med. Chem. Lett. 18, 4388\u20134392 (2008).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"95003_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.canlet.2021.05.003","volume":"513","author":"Z Liang","year":"2021","unstructured":"Liang, Z. et al. The binding of LDN193189 to CD133 C-terminus suppresses the tumorigenesis and immune escape of liver tumor-initiating cells. Cancer Lett. 513, 90\u2013100 (2021).","journal-title":"Cancer Lett."},{"key":"95003_CR28","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1158\/0008-5472.CAN-17-0112","volume":"77","author":"Y Yokoyama","year":"2017","unstructured":"Yokoyama, Y. et al. Autocrine BMP-4 signaling is a therapeutic target in colorectal cancer. Cancer Res. 77, 4026\u20134038 (2017).","journal-title":"Cancer Res."},{"key":"95003_CR29","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1074\/jbc.M114.604397","volume":"290","author":"D Horbelt","year":"2015","unstructured":"Horbelt, D. et al. Small molecules dorsomorphin and LDN-193189 inhibit myostatin\/GDF8 signaling and promote functional myoblast differentiation. J. Biol. Chem. 290, 3390\u20133404 (2015).","journal-title":"J. Biol. Chem."},{"key":"95003_CR30","first-page":"4915","volume":"117","author":"AU Steinbicker","year":"2011","unstructured":"Steinbicker, A. U. et al. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood J. Am. Soc. Hematol. 117, 4915\u20134923 (2011).","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"95003_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev.phyto.38.1.461","volume":"38","author":"ME Daub","year":"2000","unstructured":"Daub, M. E. & Ehrenshaft, M. The photoactivated cercospora toxin Cercosporin: contributions to plant disease and fundamental biology. Annu. Rev. Phytopathol. 38, 461\u2013490 (2000).","journal-title":"Annu. Rev. Phytopathol."},{"key":"95003_CR32","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1104\/pp.73.3.855","volume":"73","author":"ME Daub","year":"1983","unstructured":"Daub, M. E. & Hangarter, R. P. Light-induced production of singlet oxygen and superoxide by the fungal toxin, Cercosporin. Plant Physiol. 73, 855\u2013857 (1983).","journal-title":"Plant Physiol."},{"key":"95003_CR33","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1128\/EC.3.4.932-943.2004","volume":"3","author":"A Sussman","year":"2004","unstructured":"Sussman, A. et al. Discovery of cercosporamide, a known antifungal natural product, as a selective Pkc1 kinase inhibitor through high-throughput screening. Eukaryot. Cell. 3, 932\u2013943 (2004).","journal-title":"Eukaryot. Cell"},{"key":"95003_CR34","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1167\/iovs.14-14154","volume":"55","author":"JM Weller","year":"2014","unstructured":"Weller, J. M. et al. Extracellular matrix alterations in late-onset Fuchs\u2019 corneal dystrophy. Investig. Ophthalmol. Vis. Sci. 55, 3700\u20133708 (2014).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"95003_CR35","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/labinvest.2015.111","volume":"95","author":"N Okumura","year":"2015","unstructured":"Okumura, N. et al. Involvement of ZEB1 and Snail1 in excessive production of extracellular matrix in Fuchs endothelial corneal dystrophy. Lab. Invest. 95, 1291\u20131304. https:\/\/doi.org\/10.1038\/labinvest.2015.111 (2015).","journal-title":"Lab. Invest."},{"key":"95003_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1167\/iovs.65.4.38","volume":"65","author":"A Tchatchouang","year":"2024","unstructured":"Tchatchouang, A., Brunette, I., Rochette, P. J. & Proulx, S. Expression and impact of fibronectin, Tenascin-C, osteopontin, and type XIV collagen in Fuchs endothelial corneal dystrophy. Investig. Ophthalmol. Vis. Sci. 65, 38\u201338 (2024).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"95003_CR37","doi-asserted-by":"publisher","first-page":"10401","DOI":"10.1038\/s41598-023-37104-1","volume":"13","author":"T Nakagawa","year":"2023","unstructured":"Nakagawa, T. et al. Shotgun proteomics identification of proteins expressed in the Descemet\u2019s membrane of patients with Fuchs endothelial corneal dystrophy. Sci. Rep. 13, 10401. https:\/\/doi.org\/10.1038\/s41598-023-37104-1 (2023).","journal-title":"Sci. Rep."},{"key":"95003_CR38","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1167\/iovs.16-21023","volume":"58","author":"N Okumura","year":"2017","unstructured":"Okumura, N. et al. Sustained activation of the unfolded protein response induces cell death in Fuchs\u2019 endothelial corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 58, 3697\u20133707. https:\/\/doi.org\/10.1167\/iovs.16-21023 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95003_CR39","doi-asserted-by":"publisher","first-page":"6801","DOI":"10.1038\/s41598-017-06924-3","volume":"7","author":"N Okumura","year":"2017","unstructured":"Okumura, N. et al. Activation of TGF-\u03b2 signaling induces cell death via the unfolded protein response in Fuchs endothelial corneal dystrophy. Sci. Rep. 7, 6801. https:\/\/doi.org\/10.1038\/s41598-017-06924-3 (2017).","journal-title":"Sci. Rep."},{"key":"95003_CR40","doi-asserted-by":"publisher","unstructured":"Jurkunas, U. V., Bitar, M. S., Funaki, T. & Azizi, B. Evidence of oxidative stress in the pathogenesis of Fuchs endothelial corneal dystrophy. Am. J. Pathol. 177, 2278\u20132289, https:\/\/doi.org\/10.2353\/ajpath.2010.100279 S0002-9440(10)60281-7 [pii] (2010).","DOI":"10.2353\/ajpath.2010.100279"},{"key":"95003_CR41","doi-asserted-by":"publisher","first-page":"9291","DOI":"10.1167\/iovs.11-8312","volume":"52","author":"B Azizi","year":"2011","unstructured":"Azizi, B. et al. p53-regulated increase in oxidative-stress\u2013induced apoptosis in Fuchs endothelial corneal dystrophy: a native tissue model. Invest. Ophthalmol. Vis. Sci. 52, 9291\u20139297. https:\/\/doi.org\/10.1167\/iovs.11-8312 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"95003_CR42","doi-asserted-by":"publisher","unstructured":"Engler, C. et al. Unfolded protein response in fuchs endothelial corneal dystrophy: a unifying pathogenic pathway? Am J Ophthalmol 149, 194\u2013202 e192, (2010). https:\/\/doi.org\/10.1016\/j.ajo.2009.09.009","DOI":"10.1016\/j.ajo.2009.09.009"},{"key":"95003_CR43","doi-asserted-by":"publisher","unstructured":"Kumar, V. & Jurkunas, U. V. Mitochondrial Dysfunction and Mitophagy in Fuchs Endothelial Corneal Dystrophy. Cells 10, (2021). https:\/\/doi.org\/10.3390\/cells10081888","DOI":"10.3390\/cells10081888"},{"key":"95003_CR44","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/hmg\/ddr473","volume":"21","author":"AS Jun","year":"2012","unstructured":"Jun, A. S. et al. An alpha 2 collagen VIII Transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis. Hum. Mol. Genet. 21, 384\u2013393. https:\/\/doi.org\/10.1093\/hmg\/ddr473 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"95003_CR45","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41597-020-00754-1","volume":"7","author":"Y Tokuda","year":"2020","unstructured":"Tokuda, Y. et al. Transcriptome dataset of human corneal endothelium based on ribosomal RNA-depleted RNA-Seq data. Sci. Data. 7, 407. https:\/\/doi.org\/10.1038\/s41597-020-00754-1 (2020).","journal-title":"Sci. Data"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95003-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T11:11:49Z","timestamp":1745665909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95003-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95003"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95003-z","relation":{"references":[{"id-type":"doi","id":"10.3389\/fphar.2021.688227","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Naoki Okumura and Noriko Koizumi are co-founders of ActualEyes Inc., which is currently developing a pharmaceutical therapy for treating Fuchs endothelial corneal dystrophy. Other authors do not have a competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14665"}}